2.69
price down icon1.82%   -0.05
after-market アフターアワーズ: 2.68 -0.010 -0.37%
loading

Fortress Biotech Inc (FBIO) 最新ニュース

pulisher
May 25, 2026

Fortress Biotech Preferred Shares (FBIOP) Advance 2.45% as Support Holds Near $16MAMA Signal - Newser

May 25, 2026
pulisher
May 24, 2026

FBIO Q4 2025 Earnings: Deep EPS Miss Highlights Challenges for Pre-Revenue BiotechTrough Earnings Signal - Newser

May 24, 2026
pulisher
May 23, 2026

(FBIOP) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

May 23, 2026
pulisher
May 22, 2026

Fortress Biotech Preferred Stock (FBIOP) Q4 2025 Earnings: EPS Misses Estimates by Over 108%Community Sell Signals - Newser

May 22, 2026
pulisher
May 22, 2026

Fortress Biotech (FBIO) Gains 1.62% as Shares Approach Key Resistance at $2.97Stock Analysis - Newser

May 22, 2026
pulisher
May 22, 2026

Fortress Biotech Inc. (FBIO) Moves Higher as Buyers Defend Key Support LevelChaikin Flow - Newser

May 22, 2026
pulisher
May 22, 2026

FBIOP Stock Price, Quote & Chart | FORTRESS BIOTECH INCFBIO 9 3/8 PERP (NASDAQ:FBIOP) - ChartMill

May 22, 2026
pulisher
May 21, 2026

Fortress Biotech (FBIO) Q4 2025 Results Miss Estimates — EPS $-0.01 vs $0.11Consensus Beat Rate - Newser

May 21, 2026
pulisher
May 20, 2026

Fortress Biotech (FBIO) Q4 2025 Earnings: Miss Sparks ConcernGAAP Earnings Report - Newser

May 20, 2026
pulisher
May 20, 2026

Fortress Biotech (FBIO) Q4 2025 Miss: What Went WrongGuidance Downgrade Alert - Newser

May 20, 2026
pulisher
May 19, 2026

Journey Medical CEO to join online talk at A.G.P. health event - Stock Titan

May 19, 2026
pulisher
May 19, 2026

Fortress Biotech to Participate in A.G.P.’s Annual Virtual Healthcare Conference - Sahm

May 19, 2026
pulisher
May 18, 2026

A. G. P. Maintains Fortress Biotech(FBIO.US) With Buy Rating, Raises Target Price to $5 - Moomoo

May 18, 2026
pulisher
May 18, 2026

Why Fortress Biotech (FBIO) Just Surged +5.81% — Key Levels Ahead 2026-05-18Factor Timing - Newser

May 18, 2026
pulisher
May 18, 2026

FBIO Stock Surges 12% Pre-Market After It Wins FDA Approval For Rare Pediatric Menkes Disease - Stocktwits

May 18, 2026
pulisher
May 17, 2026

Number of shareholders of Fortress Biotech, Inc. – NASDAQ:FBIO - TradingView

May 17, 2026
pulisher
May 17, 2026

Fortress Biotech, Inc.9.375% Series A Cumulative Redeemable Perpetual Preferred Stock - TradingView

May 17, 2026
pulisher
May 16, 2026

Fortress Biotech stock (US32015L1035): FDA setback hits Menkes drug while investors eye next catalys - AD HOC NEWS

May 16, 2026
pulisher
May 15, 2026

Fortress Biotech Inc at Planet MicroCap Showcase Virtual Investor Conference 2020 Transcript - GuruFocus

May 15, 2026
pulisher
May 15, 2026

Highbridge (FBIO) reports 2.73M warrant-backed shares, 7.8% stake - Stock Titan

May 15, 2026
pulisher
May 15, 2026

FBIOP | Fortress Biotech, Inc. 9.375% Insider Trading - Quiver Quantitative

May 15, 2026
pulisher
May 14, 2026

Fortress Biotech (FBIO) Q1: EPS $2.82 Beats Est. -$0.22; Revenue - GuruFocus

May 14, 2026
pulisher
May 14, 2026

Fortress Biotech Q1 2026 Earnings Call Transcript - MarketBeat

May 14, 2026
pulisher
May 14, 2026

Fortress Biotech: Q1 Earnings Snapshot - marketscreener.com

May 14, 2026
pulisher
May 14, 2026

Fortress Biotech, Inc. 1Q 2026: Revenue $15.92M, Net income $110.37M, EPS $2.82— 10-Q Summary - TradingView

May 14, 2026
pulisher
May 14, 2026

Fortress Biotech posts $108.4M net income in Q1 2026, revenue $16.0M - TradingView

May 14, 2026
pulisher
May 14, 2026

Priority review voucher sale drives Fortress Biotech (FBIO) Q1 2026 profit and cash surge - Stock Titan

May 14, 2026
pulisher
May 14, 2026

Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 14, 2026
pulisher
May 14, 2026

Fortress Biotech (NASDAQ: FBIO) turns Q1 2026 profit after $205M PRV sale - Stock Titan

May 14, 2026
pulisher
May 14, 2026

Fortress Biotech Reports First Quarter 2026 Financial Results and Recent Corporate Highlights - Yahoo Finance

May 14, 2026
pulisher
May 14, 2026

Fortress Biotech stock (US32015L1035): Q1 earnings miss on revenue, but EMROSI shows momentum - AD HOC NEWS

May 14, 2026
pulisher
May 13, 2026

Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights - marketscreener.com

May 13, 2026
pulisher
May 12, 2026

(FBIOP) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

May 12, 2026
pulisher
May 11, 2026

TradingKey - TradingKey

May 11, 2026
pulisher
May 09, 2026

MSN Money - MSN

May 09, 2026
pulisher
May 08, 2026

Fortress Biotech Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView

May 08, 2026
pulisher
May 08, 2026

Earnings Preview: FBIO to Report Financial Results Post-market on May 13 - Moomoo

May 08, 2026
pulisher
May 06, 2026

Journey Medical to discuss quarterly results and corporate update May 13 - Stock Titan

May 06, 2026
pulisher
May 05, 2026

Mustang Bio (NASDAQ: MBIO) reports Q1 loss, limited cash and Nasdaq bid-price risk - Stock Titan

May 05, 2026
pulisher
May 04, 2026

Fortress Biotech CEO to speak at royalty company virtual conference - Stock Titan

May 04, 2026
pulisher
May 04, 2026

Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference - marketscreener.com

May 04, 2026
pulisher
May 01, 2026

(FBIOP) Risk Channels and Responsive Allocation - Stock Traders Daily

May 01, 2026
pulisher
Apr 29, 2026

FBIO Stock Price, Quote & Chart | FORTRESS BIOTECH INC (NASDAQ:FBIO) - ChartMill

Apr 29, 2026
pulisher
Apr 28, 2026

Fortress Biotech to Receive $205M as Cyprium Agrees Sale of Rare Pediatric Disease Priority Review Voucher - MSN

Apr 28, 2026
pulisher
Apr 28, 2026

Executive pay, ownership and auditor up for vote at Fortress Biotech (NASDAQ: FBIO) - Stock Titan

Apr 28, 2026
pulisher
Apr 27, 2026

What Is Driving Performance | Fortress Biotech posts 108.9% negative EPS miss vs estimatesWall Street Picks - Newser

Apr 27, 2026
pulisher
Apr 26, 2026

Why Is Fortress Biotech Stock Falling Today? - MSN

Apr 26, 2026
pulisher
Apr 25, 2026

Fortress Bio gains on FDA approval of copper replacement therapy - MSN

Apr 25, 2026
pulisher
Apr 23, 2026

Fortress (FBIOP) Market Conditions | Fortress Biotech pref posts 108.9% steep EPS missInvestor Call - Cổng thông tin điện tử tỉnh Lào Cai

Apr 23, 2026
pulisher
Apr 22, 2026

Fortress (FBIOP) Investment Case | Q4 2025: Earnings Fall ShortCrowd Trend Signals - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 22, 2026
$29.66
price down icon 0.98%
$92.25
price up icon 0.12%
$108.87
price up icon 2.48%
$53.86
price down icon 1.17%
ONC ONC
$302.44
price down icon 2.52%
$154.89
price up icon 2.20%
大文字化:     |  ボリューム (24 時間):